<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Di Agostino S</submitter><funding>Ministero dell'Università e della Ricerca</funding><funding>Ministero dell&amp;apos;Università e della Ricerca</funding><funding>NextGenerationEU</funding><pagination>247</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12372361</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>44(1)</volume><pubmed_abstract>The tumor microenvironment (TME) plays a pivotal role in the development and progression of colorectal cancer (CRC), yet the complex crosstalk among its components remains incompletely understood. Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs) have emerged as key regulators of CRC progression, but their specific contributions, particularly given their heterogeneity, are not fully elucidated. This study identifies podoplanin (PDPN), a transmembrane glycoprotein enriched in CAFs, as highly expressed in the CRC TME, in particular surrounding the tumor, and associated with macrophage infiltration and cancer progression. We performed mass spectrometry-based proteomic analysis on matched CRC and adjacent normal tissues from patients to identify altered signaling pat</pubmed_abstract><journal>Journal of experimental &amp; clinical cancer research : CR</journal><pubmed_title>Proteomic profiling identifies a stromal TGF-β1/podoplanin axis as a driver of colorectal cancer progression.</pubmed_title><pmcid>PMC12372361</pmcid><funding_grant_id>2022CMTZNH</funding_grant_id><pubmed_authors>Curro G</pubmed_authors><pubmed_authors>Cuda G</pubmed_authors><pubmed_authors>Di Agostino S</pubmed_authors><pubmed_authors>Ranieri G</pubmed_authors><pubmed_authors>Ammendola M</pubmed_authors><pubmed_authors>Aprigliano E</pubmed_authors><pubmed_authors>Urlandini L</pubmed_authors><pubmed_authors>Conforti F</pubmed_authors><pubmed_authors>Gaspari M</pubmed_authors><pubmed_authors>Zuccala V</pubmed_authors><pubmed_authors>Ieni A</pubmed_authors><pubmed_authors>La Padula D</pubmed_authors><pubmed_authors>Abbonante V</pubmed_authors><pubmed_authors>Cernaro V</pubmed_authors><pubmed_authors>Gabriele C</pubmed_authors><pubmed_authors>Vescio F</pubmed_authors><pubmed_authors>Sacconi A</pubmed_authors><pubmed_authors>Parrotta E</pubmed_authors><pubmed_authors>Lofaro D</pubmed_authors><pubmed_authors>Rago V</pubmed_authors><pubmed_authors>Alibrandi A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Proteomic profiling identifies a stromal TGF-β1/podoplanin axis as a driver of colorectal cancer progression.</name><description>The tumor microenvironment (TME) plays a pivotal role in the development and progression of colorectal cancer (CRC), yet the complex crosstalk among its components remains incompletely understood. Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs) have emerged as key regulators of CRC progression, but their specific contributions, particularly given their heterogeneity, are not fully elucidated. This study identifies podoplanin (PDPN), a transmembrane glycoprotein enriched in CAFs, as highly expressed in the CRC TME, in particular surrounding the tumor, and associated with macrophage infiltration and cancer progression. We performed mass spectrometry-based proteomic analysis on matched CRC and adjacent normal tissues from patients to identify altered signaling pat</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-05-08T10:48:02.042Z</modification><creation>2026-04-07T23:47:44.08Z</creation></dates><accession>S-EPMC12372361</accession><cross_references><pubmed>40842027</pubmed><doi>10.1186/s13046-025-03496-3</doi></cross_references></HashMap>